Evert B. Schimmelpennink Graphite Bio, Inc. (GRPH) insider trading activity

Evert B. Schimmelpennink is President, CEO and Secretary of Graphite Bio, Inc.. Currently has a direct ownership of 45,000 shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on Jul 22, 2024, when has been sold 45,000 shares (Common Stock) at a price of $1.04 per share, resulting in proceeds of $46,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45K

0% 3M change

n/a 12M change

Total Value Held $0

Evert B. Schimmelpennink Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 22 2024	BUY Exercise of conversion of derivative security	$46,800 $1.04 p/Share	45,000 Added 50.0%	45,000 Common Stock

Also insider at

IBIO

iBio, Inc. Healthcare

Director

PFNX

Pfenex Inc.

Director

CTNM

Contineum Therapeutics, Inc.

Director

EBS